Central Garden & Pet Company vs The Procter & Gamble Company: Strategic Comparison

This in-depth comparison examines Central Garden & Pet Company and The Procter & Gamble Company across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Central Garden & Pet Company on its own, evaluating The Procter & Gamble Company, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Central Garden & Pet Company and The Procter & Gamble Company is widest.

On the headline numbers, annual revenue is $3.1B (FY2025) for Central Garden & Pet Company and $87.0B (FY2026) for The Procter & Gamble Company, while their respective market capitalizations stand at $2.4B and $340.0B. Both Central Garden & Pet Company and The Procter & Gamble Company are headquartered in United States. Their local markets and applicable rules may still differ.

Central Garden & Pet Company: Central Garden & Pet is less famous than the brands it owns. Shoppers know Nylabone chews, Kaytee bird food, Aqueon aquariums, Pennington grass seed or Amdro ant bait, but most do not know one Walnut Creek company makes all of them. Central sells these products through Walmart, Home Depot, Lowe's, Costco, Tractor Supply, Petco, PetSmart, Amazon and Chewy, plus independent stores. It employs over 6,800 people and trades on Nasdaq under two share classes, CENT and CENTA. The massive consumer goods manufacturer was founded in Walnut Creek, California in 1980, originally operating as a simple regional distribution company before aggressively acquiring brands to dominate the lucrative pet and gardening aisles.

The Procter & Gamble Company: Procter & Gamble is one of the world's largest consumer packaged goods companies, selling everyday brands including Tide, Pampers, Gillette, Crest, Oral-B, Charmin, Bounty, Dawn and Head & Shoulders. Founded in Cincinnati in 1837 and still headquartered there, it reported $87.0 billion in fiscal 2026 net sales, employs roughly 109,000 people and is a component of the Dow Jones Industrial Average. Its stock trades on the NYSE under PG, with a market value of roughly $340 billion in September 2026. The company is headquartered in Cincinnati, Ohio. Procter & Gamble was founded in October 1837 in Cincinnati, Ohio, by candlemaker William Procter and soapmaker James Gamble, expanding over nearly two centuries into a global consumer goods powerhouse owning iconic brands like Tide, Pampers, Gillette, Oral-B, and Head & Shoulders.

Central Garden & Pet Company and The Procter & Gamble Company pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Central Garden & Pet Company and The Procter & Gamble Company.

Central Garden & Pet Company business model: Central makes money by manufacturing and marketing its own pet and garden brands and selling them to retailers. The Pet segment covers dog and cat treats and chews, toys, small-animal and pet bird food, aquatics, equine and livestock health products (Farnam, Champion's JustiFLY) and pet beds. The Garden segment covers grass seed, wild bird feed, fertilizers, insect and weed controls, packet seeds and live plants. For decades Central also distributed other companies' products, but in 2026 it moved its lower-margin pet distribution operation into a joint venture with Phillips Pet Food & Supplies so the company could concentrate on owned brands. Pet demand is fairly steady year-round, while Garden sales are concentrated in the spring selling season.

The Procter & Gamble Company business model: P&G makes money by designing, manufacturing and marketing branded household and personal-care products that consumers buy every week, then selling them through retailers, club stores, pharmacies, distributors and e-commerce platforms. Revenue comes from five reportable segments: Fabric & Home Care (Tide, Ariel, Dawn, Downy, Febreze), the largest; Baby, Feminine & Family Care (Pampers, Always, Bounty, Charmin); Beauty (Olay, Pantene, Head & Shoulders, SK-II); Health Care (Crest, Oral-B, Vicks); and Grooming (Gillette, Venus, Braun). Walmart is its largest customer. Profit depends on premium pricing backed by product performance, purchasing and manufacturing scale, and heavy, data-driven advertising.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Central Garden & Pet Company stack up against those of The Procter & Gamble Company.

Central Garden & Pet Company competitive advantage: Central's advantage is breadth plus retail access. It owns many niche brands that hold strong positions in their categories, and it can serve the biggest home improvement, mass, pet specialty and farm retailers across both pet and garden aisles. Owning manufacturing for products like grass seed, bird feed and pet treats lets it control cost and supply, and its acquisition playbook lets it plug new brands into existing retail relationships.

The Procter & Gamble Company competitive advantage: P&G's edge is the combination of category leadership and scale. It concentrates on about ten daily-use categories where performance differences are visible to consumers (cleaning, absorbency, shaving, oral care), funds roughly $2 billion a year of R&D to keep those gaps, and uses its size to buy materials, media and logistics more cheaply than smaller rivals. Its brands are traffic drivers for retailers, which gives P&G strong shelf positioning and joint-planning relationships with chains such as Walmart, Costco and Amazon.

Future prospects matter as much as current results. The growth strategies below explain how Central Garden & Pet Company and The Procter & Gamble Company each plan to expand from here.

Central Garden & Pet Company growth strategy: Central's Central to Home strategy rests on three levers: build and grow its consumer brands, take cost out through productivity and footprint consolidation, and add brands through acquisitions. Recent deals show the pattern: TDBBS (premium natural dog chews, 2023), the U.S. assets of cattle fly-control company Champion USA and its JustiFLY line (December 2025), and the pending majority stake in TRIXIE (announced July 2026). At the same time the company is exiting lower-margin activities, such as the 2026 move of pet distribution into a joint venture with Phillips Pet Food & Supplies.

The Procter & Gamble Company growth strategy: P&G's integrated growth strategy has five parts: a portfolio focused on about ten daily-use categories, superiority across product, packaging, communication, retail execution and value, productivity savings to fund reinvestment, 'constructive disruption' of its own practices, and an agile, accountable organization. In June 2025 the company announced a two-year restructuring that includes exiting some brands and product forms in certain markets and cutting up to 7,000 non-manufacturing roles, about 15% of that workforce. Under Jejurikar the emphasis has shifted toward consumer-first innovation, digital media and faster decision-making.

A closer look at the financial trajectory of Central Garden & Pet Company and The Procter & Gamble Company rounds out the comparison.

Central Garden & Pet Company: Central's sales have drifted lower while profits improved. Net sales were $3.339 billion in fiscal 2022, $3.310 billion in 2023, $3.200 billion in 2024 and $3.129 billion in fiscal 2025 (year ended September 27, 2025). Fiscal 2025 was still a record earnings year: GAAP EPS rose to $2.55 from $1.62 and non-GAAP EPS was $2.73, and the company ended the year with a record cash position. In fiscal 2026, first-quarter sales fell 6% to $617 million on spring shipment timing. Third-quarter sales (ended June 27, 2026) fell 8% to $882 million after the pet distribution exit, but organic sales rose 2% to $862 million, gross margin widened 130 basis points to 35.9%, and adjusted EPS was $1.54. Management raised fiscal 2026 non-GAAP EPS guidance to $2.85 or better. Central does not pay a dividend and returns cash through buybacks.

The Procter & Gamble Company: P&G's finances are defined by steady sales, high margins and large cash returns rather than fast growth. Net sales rose from $65.1 billion in fiscal 2017 to $87.0 billion in fiscal 2026. In fiscal 2026 diluted EPS was $6.62 (up 2%) and core EPS was $6.89 (up 1%), with core gross and operating margins slipping 40 and 70 basis points as costs rose. The company returned more than $15 billion to shareholders, about $10.2 billion in dividends and $5 billion in buybacks, and has raised its dividend for 70 consecutive years. For fiscal 2027 it guided to 1%-3% organic sales growth and core EPS of $6.89-$7.11. Procter & Gamble (P&G) is a dominant global consumer goods corporation, maintaining a formidable market valuation frequently exceeding $350 billion.